Teva, University College London start [PET] brain imaging study to treat neurodegenerative diseases

Teva Pharmaceutical Industries and University College London (UCL) have started a brain-imaging study to uncover a new approach in neurodegenerative disease.  The two-year study, which will be carried out in 20 patients, uses PET imaging to look at microglia cells in the central nervous system (CNS). {read more here}

Suicide is a puzzle. Fewer than 10% of people with depression attempt suicide, and about 10% of those who kill themselves were never diagnosed with any mental-health condition.  Now, a study is trying to determine what happens in the brain when a person attempts suicide, and what sets such people apart. The results could help researchers to understand whether suicide is driven by certain brain biology — and is not just a symptom of a recognized mental disorder.  {read more here}

Imaging with FDG PET/CT among patients with aggressive lymphoma can help predict response to stem cell transplant, according to a study published in Radiology. {read more here}

People with post-traumatic stress disorder (PTSD) appear to have an imbalance between two of the brain’s signaling systems, a new study suggests. {read more here}

Shop Parts